GlobalData, Jan 2011, Pages: 59
and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Data on the number of clinicaltrials conducted in North America, South And Central America, Europe, Middle-East
GlobalData, Nov 2011, Pages: 78
of clinicaltrials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinicaltrial scenario
GlobalData, Oct 2011, Pages: 90
on the number of clinicaltrials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinicaltrial
GlobalData, Jan 2012, Pages: 83
of clinicaltrials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinicaltrial scenario
GlobalData, April 2011, Pages: 51
of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinicaltrials
GlobalData, Jan 2012, Pages: 92
of clinicaltrials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinicaltrial scenario
GlobalData, Jan 2011, Pages: 50
research and in-house analysis by GlobalData's team of industry experts.
Scope
- Data on the number of clinicaltrials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia
GlobalData, June 2011, Pages: 70
for the indicated disease.
Scope
- Data on the number of clinicaltrials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions
GlobalData, Jan 2012, Pages: 83
of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinicaltrials
GlobalData, Nov 2011, Pages: 86
of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinicaltrials
GlobalData, Nov 2011, Pages: 93
on the number of clinicaltrials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinicaltrial
GlobalData, Nov 2011, Pages: 93
on the number of clinicaltrials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinicaltrial
GlobalData, Nov 2011, Pages: 86
of clinicaltrials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinicaltrial scenario
GlobalData, Nov 2011, Pages: 74
on the number of clinicaltrials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinicaltrial
GlobalData, May 2011, Pages: 49
for the indicated disease.
Scope
- Data on the number of clinicaltrials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions
GlobalData, Jan 2012, Pages: 86
on the number of clinicaltrials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinicaltrial
GlobalData, Nov 2011, Pages: 79
of clinicaltrials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinicaltrial scenario
GlobalData, Nov 2011, Pages: 79
for the indicated disease.
Scope
- Data on the number of clinicaltrials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions
GlobalData, Oct 2011, Pages: 79
- Data on the number of clinicaltrials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along
GlobalData, Jan 2011, Pages: 31
and secondary research and in-house analysis by Our team of industry experts.
Scope
- Data on the number of clinicaltrials conducted in North America, South And Central America, Europe, Middle-East and Africa
